Slides
Page 1
Morgan Stanley 20 th Annual Global Healthcare Conference 13 September 2022
Page 2
Safe Harbor Statement This presentation contains forward-looking statements that are subject to various risks and uncertainties. Future results could differ materially from those described in these forward-looking statements due to certain factors, e.g. changes in business, economic and competitive conditions, regulatory reforms, results of clinical trials, foreign exchange rate fluctuations, uncertainties in litigation or investigative proceedings, the availability of financing and unforeseen impacts of international conflicts. Fresenius does not undertake any responsibility to update the forward-looking statements contained in this presentation. 2Morgan Stanley 20th Annual Global Healthcare Conference, 13 September 2022 © Fresenius SE & Co. KGaA Investor Relations & Sustainability
Page 3
02 Business Update Q2/22 03 Financials Q2/22 & Outlook 04 Attachments Agenda 3 01 Company Overview Morgan Stanley 20th Annual Global Healthcare Conference, 13 September 2022 © Fresenius SE & Co. KGaA Investor Relations & Sustainability Company Overview 02 03 04
Page 4
Our Purpose and Mission Morgan Stanley 20th Annual Global Healthcare Conference, 13 September 2022 © Fresenius SE & Co. KGaA Investor Relations & Sustainability 4 Ever better medicine for ever more people We improve people's lives by providing high quality and affordable healthcare Company Overview 02 03 04
Page 5
A Global Leader in Health Care Products and Services 5 in sales (FY/2021) € 37.5 bn Global presence in 100+ countries 100 + Long-term opportunities in growing, non-cyclical markets Leading market positions #1 300,000+ Strong financial performance and cash flow generation Employees worldwide (as of June 30, 2022) Morgan Stanley 20th Annual Global Healthcare Conference, 13 September 2022 © Fresenius SE & Co. KGaA Investor Relations & Sustainability Company Overview 02 03 04